跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROCILIK 5 MG/100 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROCILIK 5 MG/100 MG CAPSULAS DURAS
Approved
STANDARD
ROCILIK 5 MG/100 MG CAPSULAS DURAS
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 17, 2022
Approval ID
b7e370fc15e02888
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
b7e370fc15e02888
Drug Cima Aemps Name
ROCILIK 5 MG/100 MG CAPSULAS DURAS
Register Number
87238
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2022-05-17
Dosage Form
CÁPSULA DURA
Dose
5 mg/100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
ROSUVASTATINA CALCICA
5,2 mg
ACETILSALICILICO ACIDO
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 17, 2022
Approval ID
b7e370fc15e02888
Type
Standard
Back to CIMA-AEMPS Approvals